Scholars@Duke

Figure S5 from Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer

Publication ,  Other
Gupta, S; Halabi, S; Kemeny, G; Anand, M; Giannakakou, P; Nanus, DM; George, DJ; Gregory, SG; Armstrong, AJ
April 3, 2023
Published version (DOI) Publisher Link

<p>Visualization of reference vs. alternate alleles in baseline vs. progression CTCs DNA. All the COSMIC validated mutations uniquely detected in baseline and paired progression CTCs DNA was visualized in the IGV genome browser with sequence read depth coverage, shown as snapshot images.</p>

Duke Scholars

Susan Halabi
Author Susan Halabi Biostatistics & Bioinformatics, Division of Biostatistics
Andrew John Armstrong
Author Andrew John Armstrong Medicine, Medical Oncology

DOI

10.1158/1541-7786.22527281.v1

Publication Date

April 3, 2023
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gupta, S., Halabi, S., Kemeny, G., Anand, M., Giannakakou, P., Nanus, D. M., … Armstrong, A. J. (2023). Figure S5 from Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer. https://doi.org/10.1158/1541-7786.22527281.v1
Gupta, Santosh, Susan Halabi, Gabor Kemeny, Monika Anand, Paraskevi Giannakakou, David M. Nanus, Daniel J. George, Simon G. Gregory, and Andrew J. Armstrong. “Figure S5 from Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer,” April 3, 2023. https://doi.org/10.1158/1541-7786.22527281.v1.
Gupta S, Halabi S, Kemeny G, Anand M, Giannakakou P, Nanus DM, George DJ, Gregory SG, Armstrong AJ. Figure S5 from Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer. 2023.

DOI

10.1158/1541-7786.22527281.v1

Publication Date

April 3, 2023